Headquarters
Redwood City, CA
Industry
Life Sciences – Medical Device – Cardiovascular
Overview
FoxHollow designs, develops, manufactures and sells the SilverHawk Plaque Excision
System for the treatment of peripheral artery disease.
Solution
QAD Enterprise Applications was implemented to help FoxHollow prepare systems for
product commercialization and an IPO as well as to establish a robust enterprise infrastructure for expansion
and growth. The full QAD ERP implementation including validation to meet the requirements of the FDA lasted only
12 weeks.
Results
While using QAD and Strategic FoxHollow’s revenue grew from 38M to 193M. FoxHollow
was sold to ev3 for $768 M in 2007.
